2024 Beijing Sub-Center Innovation Medical Translation Competition Officially Launched, Focusing on Three Core Fields

Jun 12, 2024 08:00 CST Updated 08:00

June 11, with“Building a Demonstration Zone for Medical-Industrial Synergy, Developing New Quality Productive Forces in Health”themed2024 Beijing Municipal Administrative Center Innovative Medical Translation CompetitionOfficially launched at Yifang Health Valley, this competition is organized byGuided by the United Front Work Department of the CPC Beijing Municipal Committee, and organized by the Beijing Municipal Committee of the Chinese Peasants and Workers Democratic Party, the People’s Government of Tongzhou District, Beijing Municipality, and Capital Medical UniversityHosted by, co-organized by Yifang Health Valley and VCBeat, with People's Daily Health Client as the strategic media partner.

启动仪式.jpg

Launch Ceremony of the 2024 Beijing Sub-Center Innovative Medical Translation Competition

At the launch ceremony, representatives from each organizing body delivered opening remarks.Wu Kong'an, Member of the Standing Committee of the Tongzhou District Committee of the Communist Party of China and Deputy District MayorIt was stated that the Beijing Municipal Administrative Center, anchored by its core function of technological innovation and leveraging its inherent advantages, is committed to building a “Demonstration Zone for the Synergistic Development of Medicine and Industry.” This competition aims to provide innovative medical projects and enterprises with greater platforms for exposure and industrial space, thereby fostering new quality productive forces in the pharmaceutical and health industries. Experts, scholars, and entrepreneurs are cordially invited to gain a deeper understanding of the Municipal Administrative Center and participate in its development. The Center will offer an open environment, preferential policies, and high-quality services to jointly plan for future growth.

Jiang Xin, Standing Committee Member and Deputy Secretary-General of the Beijing Municipal Committee of the Chinese People's Political Consultative Conference (CPPCC), Member of the Central Committee of the Chinese Peasants and Workers Democratic Party (CPWDP), and Full-time Deputy Chairperson of the Beijing Municipal Committee of the CPWDPIn its statement, the Beijing Municipal Committee of the Chinese Peasants and Workers Democratic Party actively implemented the requirements of the “Special Action to Mobilize United Front Resources in the Capital to Support High-Quality Industrial Development in the City Sub-center,” giving full play to the advantages of the medical and health sector. By planning and organizing this competition, it encouraged and supported a number of outstanding medical projects, helping them achieve scientific research translation and industrialization, thereby promoting high-quality collaborative development between healthcare and industry in the sub-center through concrete actions.

Professor Chen Rui, Dean of the School of Public Health and Director of the Department of Scientific and Technological Achievement Transformation at Capital Medical UniversityIt was stated that Capital Medical University, as a key university in Beijing, actively contributes to the Healthy China and Healthy Beijing initiatives and the coordinated development of the Beijing-Tianjin-Hebei region through collaboration among its various colleges, research centers, and affiliated clinical hospitals. The joint hosting of this competition aims to jointly promote the translation of medical achievements, stimulate scientific research enthusiasm and innovation vitality, and help continuously enrich and improve the pharmaceutical and health industry ecosystem in the sub-center.

For this Innovative Medical Translation Competition, the Organizing Committee has not only invited dozens of authorities from relevant fields—including medical research, clinical practice, investment institutions, and entrepreneurship—to form the judging panel, but also established a Steering Expert Committee under the active promotion of the Beijing Municipal Committee of the Chinese Peasants and Workers Democratic Party. We are especially honored to have with us todayAcademician Jiang Jiandong, Member of the Chinese Academy of Engineering and Dean of the Institute of Materia Medica, Chinese Academy of Medical SciencesAddressing the Event: Beijing has long been a highland for technological innovation and development, with the pharmaceutical and health industries serving as a crucial engine driving the city’s innovative growth. During this visit to Huoxian Town in Tongzhou District, I have witnessed the vigorous development of the medical and health sector in the Beijing Sub-Center, where an innovative ecosystem is gradually taking shape. As a member of the Expert Committee for this competition, I hope that it will successfully accelerate the translation and implementation of a batch of outstanding frontier medical technology projects, thereby injecting new momentum into the advancement of medical science.

院士.jpg

Address by Academician Jiang Jiandong, Member of the Chinese Academy of Engineering and Dean of the Institute of Materia Medica, Chinese Academy of Medical Sciences

Build a Demonstration Zone for Medical-Industrial Collaboration to Facilitate the Implementation of Innovative Projects, Identify Business Opportunities, and Link Resources

In 2016, the national government began studying and deploying plans for the construction of Beijing’s Municipal Administrative Center. Over the past eight years, as a key component of the “One Core, Two Wings” framework for the coordinated development of the Beijing-Tianjin-Hebei region, the Beijing Municipal Administrative Center has fully leveraged its role as a bridgehead to radiate influence and drive progress, promoting the integrated high-quality development of the demonstration zone with the three northern counties of Langfang.

Amid the new wave of technological transformation, the pharmaceutical and healthcare sector, as one of the most technology-intensive, innovation-dense, and investment-active fields, represents a key direction for developing new quality productive forces. As the cluster area for Beijing’s future health industry development, the Beijing Sub-Center is leveraging its core function of technological innovation and its own advantages to build a “Demonstration Zone for Collaborative Development of Medicine and Industry” in accordance with high standards.

Leveraging the high-quality medical resources accumulated by seven tertiary hospitals, including Peking University People’s Hospital, Beijing Friendship Hospital affiliated with Capital Medical University, and Beijing Anzhen Hospital affiliated with Capital Medical University, the Beijing Sub-center provides abundant foundational support and application scenarios for medical-industrial collaboration. Currently, the pharmaceutical and health industries in the Beijing Sub-center are booming, with nearly 400 market entities related to pharmaceuticals and healthcare operating in the area, injecting strong momentum into the coordinated development of medicine and industry.

To support the development of a collaborative ecosystem between healthcare and industry, Tongzhou District has prominently released the “Ten Measures for Encouraging the Development of the Pharmaceutical and Health Industries in Beijing’s Municipal Administrative Center.” These measures focus on three key areas: “supporting medical-industrial collaboration to build distinctive industrial ecosystems,” “supporting product innovation to accelerate the realization of industrial value,” and “promoting the aggregation of essential factors to strengthen industrial service support,” thereby providing support to pharmaceutical companies, medical institutions, and various entities involved in industrial factors. Based on the new stage of industrial development in the Municipal Administrative Center, Tongzhou District has optimized and upgraded its “1+N” industrial policy framework and formulated the “Several Measures for Accelerating High-Quality Industrial Development in Beijing’s Municipal Administrative Center.” This initiative provides comprehensive assistance to enterprise development from multiple dimensions, including financial support, spatial supply, business environment optimization, and talent services.

To further promote the agglomeration of the pharmaceutical and health industries in the Beijing Municipal Administrative Center and foster the coordinated development of medicine and industry, the “2024 Beijing Municipal Administrative Center Innovative Medical Translation Competition” has officially launched! This competition aims to build key links in the translation ecosystem—connecting technology with demand, clinical practice with solutions, and enterprises with capital. It provides professional support to both supply and demand sides of achievement translation, demonstrates the synergistic model of medical-industrial collaboration, accelerates the translation of outcomes, facilitates industrial implementation, and fosters in-depth cooperation.

Following the launch ceremony and the release of the competition framework for this edition, the Tongzhou District Commission of Science and Technology presented a series of measures and policies designed to encourage innovation in the pharmaceutical and health industries and accelerate high-quality industrial development in the Beijing Sub-Center, addressing concerns from various sectors. Yifang Health Valley, the first medical and health industrial park in Tongzhou District, will serve as the venue for the semi-finals and finals of the competition, and will concurrently host the Forum on Medical Innovation and Scientific Research Translation during the final round.

大赛.png

What Will You Gain by Joining the Recruitment in Three Core Hardcore Fields?

This is a sufficiently “hardcore” innovation medical translation competition.The “hardcore” nature we discuss is manifested, on one hand, in niche sectors: The competition features three categories during the registration, preliminary, and semi-final stages: Medical Devices & Intelligent Manufacturing, Innovative Pharmaceuticals & Biologics, and Digital Health & AI. The final stage will not be divided into categories.

Medical Devices and Intelligent Manufacturing Group:Primarily covering instruments, equipment, appliances, in vitro diagnostic reagents and calibrators, materials, and other similar or related items that are used directly or indirectly on the human body;

Innovative Pharmaceuticals and Biologics Group:Primarily covering pharmaceutical projects in R&D, manufacturing, innovative drugs and biologics, or those providing innovative therapies, including substances or formulations for the prevention, treatment, or diagnosis of diseases;

Digital Healthcare and AI Group:It primarily covers healthcare service products that leverage emerging technologies such as the internet and artificial intelligence, or integrate existing technologies, to deliver more precise and efficient medical services.

The other side of the “hardcore” nature is the award structure of this competition.To identify more innovative medical technology projects with genuine high technical content and significant market potential, this Innovation in Medical Translation Competition has established not only comprehensive first, second, and third prizes but also special awards, including the Best Originality Award, the Most Promising Potential Award, the Best Application Award, and the Outstanding Talent Award. These awards evaluate entries from multiple dimensions, including policy, research and development, talent, funding, and market prospects.Provides participating enterprises with a comprehensive suite of technology transfer services, spanning from research and development to commercialization and industrial implementation.

The awards for winners of this competition include:

Financial Incentives: Drive projects and assist in introducing venture capital and startup funds.

Incubation Incentives: Complimentary office space, commercialization and incubation services, media promotion, and other professional services

Policy Incentives: Premium Project Service Package (Grant Application, Approval Guidance, Talent Services, Key Support)

To Participate in the Competition, You Must Meet These Requirements

This competition is open to all research institutes, clinical institutions, universities, and innovation R&D teams of leading enterprises in the Beijing-Tianjin-Hebei region. All submitted projects must meet the following criteria:

The project has undergone feasibility validation studies, and has either been granted a patent or received a Notice of Acceptance from the preliminary examination of the patent application. It clearly aims to achieve commercialization and practical implementation, demonstrating significant application value.

Projects registered with enterprises, teams, or individuals in the Beijing-Tianjin-Hebei region may participate individually or as a team (projects from outside the Beijing-Tianjin-Hebei region are also eligible); enterprises must be at Series A financing round or earlier.05

Projects submitted must have clear and well-defined medical application scenarios; applicants may select only one category and cannot apply under multiple categories.

Participating in the Competition: Key Dates to Note

The competition schedule is divided into three stages: initial submission and review, semi-finals, and finals. The schedule is planned as follows:

June 11–July 3: The competition will adopt a parallel model of recruitment and preliminary rounds. Participating entities may scan the QR code below to register. Interested enterprises are encouraged to register promptly to undergo online preliminary review in advance, thereby securing their spot in the finals ahead of others.

副中心.png

(Registration QR Code)

From July 3 to July 21, the Competition Organizing Committee will hold specialized sessions at the Yifang Health Valley Roadshow Hall, categorized by three groups. Project enterprises will undergo specialized evaluations and be scored based on dimensions such as market prospects, clinical value, and technological proficiency. Ten high-quality project enterprises will be selected from each group to advance to the finals.

In late July, the finals and awards ceremony will be held at the Yifang Health Valley Conference Center. At that time, winning enterprises of the competition will receive their honors at the event and gain priority access to industry chain resources. The competition results will also be simultaneously published in leading domestic industry media and financial news outlets for widespread dissemination, thereby enhancing corporate visibility and influence.

Finally, we welcome everyone to participate in the 2024 Beijing Sub-Center Innovative Medical Translation Competition. We look forward to joining you in experiencing and witnessing the birth of a future ecosystem for medical-industrial collaboration.